Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Wockhardt Limited (NSE: WOCKPHARMA), ISIN INE049B01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
WOCKPHARMA last traded at ₹2329.80 (+6.63%), with a 52-week range of ₹1086.80 to ₹2420.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 49.08%, FIIs 7.22%, DIIs 9.24%, mutual funds 6.79%.
EquiSense Score (ECS): 90/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.